ACUTROL
Brand:
ACUTROL
Manufacturer:
INTAS
Manufacturer Details
INTAS
Compositions:
Sevelamer hydrochloride tablets,
|
Strength
|
Rate
|
Packing Style
|
|
400mg
|
257.10
|
10s tablets
|
|
800mg
|
336.37
|
10s tablets
|
List of Related Indications:
- Hyperphostaemia in renal fail
List Of Drugs:
- Sevelmer Carbonate - Urinary Antocholergic- (Apr 2008)
Indication Type Description:
Indication:
U.S.FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
121. Sevelamer Carbonate 400mg/800mg tablets 28-04-08
& sachet 400mg/800mg
For the control of serum phosphates in patients
with chronic kidney disease in dialysis
Hyperphosphataemia in haemodialysis
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Sevelamer Carbonate 26-11-2009
Addl.Indcn
For the Control of serum Phosphorus in patients with chronic Kidney
Disease on Hemodialysis or Peritone AL Dialysis and Patients with
CKD not on Dialysis with serum Phosphate > 5.5 mg/dl
2.Sevalamar Carbonate 400mg/800mg 28-04-2008
Tablets & Sachet 400mg/800mg
For the control of Serum Phosphorus in patients with Chronic
Kidney disease on Dialysis
Dosages/ Overdosage Etc:
Hyperphosphataemia in haemodialysis
For the control of Serum Phosphorus in patients with Chronic
Kidney disease on Dialysis
